est.social on üks paljudest sõltumatutest Mastodoni serveritest, mida saab fediversumis osalemiseks kasutada.
est.social on mõeldud Eestis üldkasutatavaks Mastodoni serveriks. est.social is meant to be a general use Mastodon server for Estonia.

Administraator:

Serveri statistika:

91
aktiivsed kasutajad

#psychiatry

3 postitusega3 osalejaga0 postitust täna

DATE: March 26, 2025 at 02:18PM
SOURCE: PSYPOST.ORG

** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------

TITLE: Teens in poverty use social media more—but don’t suffer more because of it, study suggests

URL: psypost.org/teens-in-poverty-u

New research published in Computers in Human Behavior sheds light on how material deprivation influences teenagers’ access to and use of social media, and whether it changes the impact of social media on their emotional well-being. The study found that while teens from deprived households reported lower overall life satisfaction and spent slightly more time on social media, deprivation did not appear to worsen the link between social media use and life satisfaction. In other words, teens experiencing poverty did not seem to suffer more from time spent online compared to their more affluent peers.

The research was motivated by a growing concern over how social media affects adolescents’ well-being. Most studies in this area have treated teenagers as a single, uniform group, overlooking how individual differences—such as socioeconomic background—might shape these effects. Since social media is increasingly embedded in daily life, and teenagers are spending more time on platforms than ever before, it’s important to ask whether some young people are more vulnerable to its harms or more likely to benefit from its potential support. The authors of the study proposed that material deprivation, a measure of whether families can afford basic necessities, could be a key factor influencing how social media relates to adolescent life satisfaction.

“The discussion on the relationship between social media and adolescent wellbeing often overlooks the experiences of adolescents from deprived households. I wanted to address this gap by leveraging existing data to contribute empirical evidence to the debate,” said study author Sebastian Kurten, an assistant professor at Utrecht University.

The researchers analyzed ten years of data collected between 2009 and 2019 from the “Understanding Society” study, which tracks tens of thousands of households across the United Kingdom. This specific analysis included 23,155 adolescents aged 10 to 21, generating nearly 80,000 measurement points. These participants responded to surveys about their social media access and use, while their parents answered questions about the family’s financial situation.

The researchers used established indexes to determine whether families experienced material deprivation. For younger adolescents, this included things like not being able to afford school trips or warm winter coats. For older teens, it included items such as the inability to pay household bills or afford basic furniture.

The team used statistical modeling to sort participants into different deprivation categories and then looked at how these related to social media access, time spent on social media, and self-reported life satisfaction. Life satisfaction was measured annually through age-appropriate survey questions. For social media, they asked whether the adolescent had access to social media platforms and how many hours they typically spent using them on a school day.

The results showed that teens from deprived households were less likely to have access to social media, especially at younger ages. For example, by age 11, 76% of non-deprived adolescents had a social media account, compared to 69% of deprived teens. But by age 18, this gap disappeared—nearly all adolescents, regardless of background, had joined social media. Interestingly, among those with access, teens from deprived households reported spending slightly more time on social media than their wealthier peers.

Across the entire group, spending more time on social media was associated with slightly lower life satisfaction. However, this connection was modest and consistent regardless of socioeconomic background. Deprivation was strongly linked to lower life satisfaction overall, but it did not appear to make the effect of social media use any worse. Even when the researchers used sophisticated longitudinal modeling to track changes within individuals over time, they found no evidence that deprivation influenced how social media use affected life satisfaction in the long term.

The study also tested whether having access to social media—rather than the amount of time spent—was related to emotional well-being. Again, results were mixed. In one analysis, teens from deprived households who had social media access were slightly more likely to report lower life satisfaction, but this finding was weak and not consistent across all models. And in the long-term analysis, there was no sign that deprivation shaped how social media access influenced well-being.

“Poverty poses a significant threat to the wellbeing and development of adolescents,” Kurten told PsyPost. “While there is intense debate about the impact of social media on adolescent mental health, structural issues such as poverty and material deprivation are often overlooked. These factors create lasting disadvantages for adolescents and deserve more attention in public discourse.”

While the research provides some reassurance that social media does not appear to be especially harmful for adolescents growing up in poverty, the authors caution against drawing overly broad conclusions. One limitation is that the study relied on self-reported data about social media use, which may be prone to error. Teenagers may overestimate or underestimate how much time they spend online, and the survey did not distinguish between different types of social media activity.

“We used representative panel data from the UK collected several years ago, but at the time, social media use was assessed with a simple 1-to-5 scale rather than more nuanced measures,” Kurten noted. “Fortunately, research has since advanced, and newer studies use more sophisticated assessments. However, the general trends observed in our data align with findings from studies that employ these improved measures.”

Despite these limitations, the researchers argue that their findings challenge some common assumptions. While it’s often suggested that social media use might be especially harmful for deprived youth, this study did not support that idea. Instead, the authors suggest that material deprivation itself is a more consistent predictor of lower well-being than social media use. This points to the need for policies that address poverty directly, rather than focusing narrowly on social media as a cause of distress.

“My long-term goal is to provide more comprehensive evidence on how structural adversities, such as material deprivation, affect adolescent wellbeing,” Kurten said. “I want to make sure that their perspectives also get heard in the public debate.”

“I would be glad to see the public debate shift from focusing solely on what social media does to children to addressing the far greater impact of poverty. My research highlights that material deprivation is a structural issue with serious consequences for adolescent wellbeing. We need to intensify our efforts to lift children out of poverty and ensure they have the resources to thrive.”

The study, “Deprivation’s role in adolescent social media use and its links to life satisfaction,” was authored by Sebastian Kurten, Sakshi Ghai, Candice Odgers, Rogier A. Kievit, and Amy Orben.

URL: psypost.org/teens-in-poverty-u

-------------------------------------------------

Private, vetted email list for mental health professionals: clinicians-exchange.org

Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

READ ONLINE: read-the-rss-mega-archive.clin

It's primitive... but it works... mostly...

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist

PsyPost · Teens in poverty use social media more—but don’t suffer more because of it, study suggestsEric W. Dolan poolt

"Among the most consequential orders is the requirement that thousands of mental health providers, including many who were hired for fully remote positions, now work full time from federal office space. This is a jarring policy reversal for the V.A., which pioneered the practice of virtual health care two decades ago as a way to reach isolated veterans, long before the pandemic..."

nytimes.com/2025/03/22/us/poli

The New York Times · Trump and DOGE Propel V.A. Mental Health System Into TurmoilEllen Barry poolt

DATE: March 23, 2025 at 12:00PM
SOURCE: PSYPOST.ORG

** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------

TITLE: Study finds microdosing LSD is not effective in reducing ADHD symptoms

URL: psypost.org/study-finds-microd

A new clinical trial has found that taking low doses of LSD twice a week does not reduce symptoms of attention-deficit/hyperactivity disorder in adults more than a placebo. While both the LSD and placebo groups showed improvements over six weeks, there was no meaningful difference between the two. These results challenge popular claims about the benefits of microdosing psychedelics and emphasize the importance of placebo-controlled studies when evaluating treatments that are often promoted through anecdotal evidence. The research was published in JAMA Psychiatry.

Attention-deficit/hyperactivity disorder, more commonly known as ADHD, affects nearly three percent of adults worldwide. The condition involves persistent difficulties with attention, impulsivity, and hyperactivity, often leading to significant struggles in work, relationships, and daily functioning. Standard treatments typically include stimulant medications like amphetamines or methylphenidate, which can be effective but don’t work for everyone. About one in three patients don’t get enough relief, and many stop taking the medications due to side effects or concerns about long-term use.

In recent years, the idea of microdosing psychedelics—taking very small amounts of substances like LSD or psilocybin—has gained popularity. Some users claim that microdosing improves focus, emotional balance, and creativity, and many report using it to self-treat conditions such as depression, anxiety, and ADHD. Microdoses are usually about one-tenth of a recreational dose, small enough that they don’t cause noticeable changes in perception. But despite the enthusiasm online and in the media, there has been little clinical research testing whether microdosing actually works as a treatment.

To test these claims, researchers from University Hospital Basel in Switzerland and Maastricht University in the Netherlands conducted a six-week, placebo-controlled trial. They recruited 53 adults diagnosed with moderate to severe ADHD and randomly assigned them to receive either a low dose of LSD or a placebo. The study was double-blind, meaning neither the participants nor the researchers knew who was receiving which treatment.

“We were contracted by the company Mindmed to perform this work which was within our line of work on psychedelics,” explained study author Matthias Liechti, the head of the Clinical Pharmacology Division of the University Hospital Basel.

Participants were given their assigned substance twice a week under supervision. The dose of LSD—20 micrograms—is considered to be at the higher end of the microdosing range and was chosen to increase the chance of detecting any therapeutic benefit. Throughout the study, participants completed various assessments measuring ADHD symptoms, including both self-reported and observer-rated scales. Researchers also collected information about side effects, vital signs, and subjective drug experiences.

By the end of the six weeks, both the LSD and placebo groups had shown significant reductions in ADHD symptoms. On the primary measure, symptoms improved by an average of 7.1 points in the LSD group and 8.9 points in the placebo group. This difference was not statistically meaningful. Across all other symptom ratings and time points, the two groups continued to show nearly identical improvements.

Participants in both groups also experienced similar benefits when they believed they were receiving the active drug. Interestingly, after the final dose, 80% of participants—whether they had taken LSD or placebo—guessed they had received LSD. Those who believed they had taken LSD tended to report greater symptom improvement, regardless of what they had actually received. This suggests that expectations may have played a large role in how participants experienced the treatment.

“In a well-designed study, low dose LSD (microdosing) is not more effective than placebo in patients with ADHD,” Liechti told PsyPost. “We observed marked therapeutic improvements in many patients and were surprised to see at the end of the study that they were equally frequent in the placebo group. Both LSD and placebo are effective over time but placebo and expectancy effects are the reason for this, not the LSD effect. This highlights the need for a well-blinded placebo control group.”

As expected, participants who took LSD did experience more noticeable short-term drug effects, such as changes in perception and feelings of altered consciousness. These effects were mild but significantly stronger than those reported by the placebo group. Still, the LSD dose used in the study was well tolerated overall. The most common side effects were headache, nausea, fatigue, insomnia, and mild visual changes. Two participants dropped out of the LSD group due to uncomfortable effects. There were no serious medical events or psychiatric complications.

Although the study did not find LSD to be effective for treating ADHD, it does offer some important insights. First, it shows that low doses of LSD can produce measurable but tolerable psychological effects in a clinical setting. It also demonstrates that strong placebo responses are possible in psychedelic studies, even when the dose is too low to cause intense hallucinations. This supports concerns that anecdotal reports of success with microdosing may be driven more by belief than biology.

The researchers also noted that the study was one of the few in psychedelic research to achieve successful blinding. In most psychedelic trials, the noticeable effects of high doses make it easy for participants to guess whether they’re receiving the active substance. In this case, the use of a low dose meant that even placebo recipients often believed they had received LSD, reducing the influence of expectation bias to some extent.

Although some past studies have suggested that higher doses of LSD may help with anxiety or depression, this trial does not provide evidence that low doses help with ADHD. Further research is needed to explore other psychedelics and different dosing schedules.

“The study used a relatively high dose of 20 micrograms, but a lower dose of 10 micrograms—or a dosing schedule of every day or every other day—might produce different results,” Liechti said. “It is not likely though. High-doses of LSD have consistently been shown to be effective in anxiety and depressive disorders. Thus, such high doses may also be effective in the treatment of mood in ADHD patients.”

The study, “Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial,” was authored by Lorenz Mueller, Joyce Santos de Jesus, Yasmin Schmid, Felix Müller, Anna Becker, Aaron Klaiber, Isabelle Straumann, Dino Luethi, Eline C. H. M. Haijen, Petra P. M. Hurks, Kim P. C. Kuypers, and Matthias E. Liechti.

URL: psypost.org/study-finds-microd

-------------------------------------------------

Private, vetted email list for mental health professionals: clinicians-exchange.org

Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

READ ONLINE: read-the-rss-mega-archive.clin

It's primitive... but it works... mostly...

-------------------------------------------------

#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist

PsyPost · Study finds microdosing LSD is not effective in reducing ADHD symptomsEric W. Dolan poolt

SERRCissä kriittistä pohdintaa itsesurmaamisen tutkimisesta ja ehkäisystä, social-epistemology.com/2025/0

Osa 2 löytyy tuon perästä ja tästä: social-epistemology.com/2025/0

Lähteissä en huomannut SEP-entryä, joka on hyvä johdatus käsitteeseen, plato.stanford.edu/entries/sui. Viime päivinä näkyy maailmalla kohistun monimutkaisia päätöstilanteita ja nopeaa ja hidasta ajattelua tutkineen Daniel Kahnemanin avustetusta itsesurmasta, vaikka se tapahtui liki vuosi sitten.

Social Epistemology Review and Reply Collective · A Critical Inventory of Suicidology and Suicide Prevention, Part I, Michaela Hintermayr

Our #OpenAccess #book fund is showing real results! One of our supported researchers, Stephan Schleim, shared that their book "#Brain Development and the #Law: #Neurolaw in Theory and Practice" has been downloaded over 4,000 times!

🔗 link.springer.com/book/10.1007

Stephan's publication was part of the first funding cycle that contributed to the publication of 47 open access books.

🔗 rug.nl/library/open-access/fun

SpringerLinkBrain Development and the LawThis open access book is the first to offer a systematic overview of the different methods for assessing brain development

TITLE: Microsoft Copilot: Data Privacy Violation? *How to Turn it Off*

Microsoft Copilot is now built into Windows 10 and 11 and highly integrated with all Office 365 apps.

It is arguably highly useful.

However (at least in Word), the entire point of Copilot is to learn from what you type, and suggest or write increasingly useful documents. This means it is learning from your confidential client documents -- so the question arises -- how far does that information spread and does it even understand what is confidential and what is not?

Personally -- I want to selectively engage AI as *I* need it, and not have it looking over my shoulder at all times.

In this video, a lawyer breaks down a conversation between another lawyer and a Microsoft employee addressing pointed conversations about confidentiality. The employee seems to say that confidential information won't transmit beyond your organization (if you are using a business license version of Office 365...) but leaves unclear whether or not confidential information might spread between employees in the same business on a group license. Then there is the whole question of whether or not to even trust that Microsoft is not sucking up the data from your client documents regardless of what they say (their licensing documents *ALLOW THIS*). This is *THE* video to watch right now concerning privacy and HIPAA implications: youtube.com/watch?v=W9X6yMwmMp

If you are viewing this on a web browser, also look at the comment section.

Please note that 4:48 into the video it discusses how to turn off Copilot in Office. Great. I tested this, and it also turns off my ability to synch OneNote documents with the cloud and different computers. So be aware of that.

This webpage gives you an easy way to turn off Copilot using the Group Policy Editor:
tomsguide.com/computing/softwa

This also works for Windows 10. You have to have a Pro, Enterprise, or Education edition of Windows to use the Group Policy Editor. Otherwise, you will need to use the Registry Editor. You can find directions on how to do this in this conversation: answers.microsoft.com/en-us/wi

Turning off Copilot through the Group Policy Editor does NOT damage my ability to synch OneNote files with OneDrive and between computers. (Moving to a solution that does not require this is a future goal of mine as its a security concern too...)

Meanwhile, Atomic Shrimp (a channel usually devoted to scam baiting -- highly amusing, I recommend him) apparently considers this all a scam. In a nutshell -- the price of Office 365 has been increased and Copilot has been added to it. However, if you are willing to wait on-hold 1-3 hours and argue with Microsoft, they still have an unadvertised tier of Office 365 at the old price WITHOUT Copilot functionality:
Microsoft’s Sneaky Forced-Upsell to 365 Users; If You Don’t Need/Want Copilot, Don’t Pay for It
youtube.com/watch?v=eYVPThx7ys

So -- I guess I'd rather pay the higher price each year for Office 365 and just turn off Copilot, but to each their own... But then, the software still exists on our computers, so in theory it might still be functioning if Microsoft is lying...

It's time to switch to Linux Mint and move out of the Microsoft sphere.

If you missed it earlier:

a) Turn off Recall: youtube.com/watch?v=HMi6UaO1In
b) What Microsoft User Agreements say about their rights to use your data:
youtube.com/watch?v=1bxz2KpbNn

I happen to have a HIPAA BAA agreement with Microsoft, but really -- am I going to sue Microsoft if they violate it?

At the risk of getting political, keep in mind that Microsoft just gave $1 million to the Trump inauguration fund. Perhaps just a savvy business move to stay in favor. It gets more ominous if we read into it, in light of likely administration future moves against transgender rights, LGBTQ+ rights, non-Christian religions, and pregnancy concerns -- all concerns we are likely to encounter as psychotherapists. All concerns we MIGHT document in client materials...

-- Michael

--
Michael Reeder LCPC
Hygeia Counseling Services : Baltimore, Maryland

~~~
#microsoft #eula #privacy #hipaa #healthcare #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #PsiAN #psychotherapist #psychoanalytic #psychodynamic #depththerapy #security #securitynews #hospital #socialwork #healthcaresecurity #BAA #patientrecords